Neurexin I alpha is a major alpha-latrotoxin receptor that cooperates in alpha-latrotoxin action. 1998

M Geppert, and M Khvotchev, and V Krasnoperov, and Y Goda, and M Missler, and R E Hammer, and K Ichtchenko, and A G Petrenko, and T C Südhof
Max-Planck-Institut für Experimentelle Medizin, Göttingen, Germany.

alpha-Latrotoxin is a potent neurotoxin from black widow spider venom that binds to presynaptic receptors and causes massive neurotransmitter release. A surprising finding was the biochemical description of two distinct cell surface proteins that bind alpha-latrotoxin with nanomolar affinities; Neurexin I alpha binds alpha-latrotoxin in a Ca(2+)-dependent manner, and CIRL/latrophilin binds in a Ca(2+)-independent manner. We have now generated and analyzed mice that lack neurexin I alpha to test its importance in alpha-latrotoxin action. alpha-Latrotoxin binding to brain membranes from mutant mice was decreased by almost 50% compared with wild type membranes; the decrease was almost entirely due to a loss of Ca(2+)-dependent alpha-latrotoxin binding sites. In cultured hippocampal neurons, alpha-latrotoxin was still capable of activating neurotransmission in the absence of neurexin I alpha. Direct measurements of [3H]glutamate release from synaptosomes, however, showed a major decrease in the amount of release triggered by alpha-latrotoxin in the presence of Ca2+. Thus neurexin I alpha is not essential for alpha-latrotoxin action but contributes to alpha-latrotoxin action when Ca2+ is present. Viewed as a whole, our results show that mice contain two distinct types of alpha-latrotoxin receptors with similar affinities and abundance but different properties and functions. The action of alpha-latrotoxin may therefore be mediated by independent parallel pathways, of which the CIRL/latrophilin pathway is sufficient for neurotransmitter release, whereas the neurexin I alpha pathway contributes to the Ca(2+)-dependent action of alpha-latrotoxin.

UI MeSH Term Description Entries
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D009435 Synaptic Transmission The communication from a NEURON to a target (neuron, muscle, or secretory cell) across a SYNAPSE. In chemical synaptic transmission, the presynaptic neuron releases a NEUROTRANSMITTER that diffuses across the synaptic cleft and binds to specific synaptic receptors, activating them. The activated receptors modulate specific ion channels and/or second-messenger systems in the postsynaptic cell. In electrical synaptic transmission, electrical signals are communicated as an ionic current flow across ELECTRICAL SYNAPSES. Neural Transmission,Neurotransmission,Transmission, Neural,Transmission, Synaptic
D009479 Neuropeptides Peptides released by NEURONS as intercellular messengers. Many neuropeptides are also hormones released by non-neuronal cells. Neuropeptide
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D002874 Chromosome Mapping Any method used for determining the location of and relative distances between genes on a chromosome. Gene Mapping,Linkage Mapping,Genome Mapping,Chromosome Mappings,Gene Mappings,Genome Mappings,Linkage Mappings,Mapping, Chromosome,Mapping, Gene,Mapping, Genome,Mapping, Linkage,Mappings, Chromosome,Mappings, Gene,Mappings, Genome,Mappings, Linkage
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013111 Spider Venoms Venoms of arthropods of the order Araneida of the ARACHNIDA. The venoms usually contain several protein fractions, including ENZYMES, hemolytic, neurolytic, and other TOXINS, BIOLOGICAL. Araneid Venoms,Spider Toxin,Spider Toxins,Tarantula Toxin,Tarantula Toxins,Tarantula Venom,Araneid Venom,Spider Venom,Tarantula Venoms,Toxin, Spider,Toxin, Tarantula,Toxins, Spider,Toxins, Tarantula,Venom, Araneid,Venom, Spider,Venom, Tarantula,Venoms, Araneid,Venoms, Spider,Venoms, Tarantula

Related Publications

M Geppert, and M Khvotchev, and V Krasnoperov, and Y Goda, and M Missler, and R E Hammer, and K Ichtchenko, and A G Petrenko, and T C Südhof
October 1996, Biochemical and biophysical research communications,
M Geppert, and M Khvotchev, and V Krasnoperov, and Y Goda, and M Missler, and R E Hammer, and K Ichtchenko, and A G Petrenko, and T C Südhof
October 1995, The Journal of biological chemistry,
M Geppert, and M Khvotchev, and V Krasnoperov, and Y Goda, and M Missler, and R E Hammer, and K Ichtchenko, and A G Petrenko, and T C Südhof
May 1999, Cell and tissue research,
M Geppert, and M Khvotchev, and V Krasnoperov, and Y Goda, and M Missler, and R E Hammer, and K Ichtchenko, and A G Petrenko, and T C Südhof
November 2000, The European journal of neuroscience,
M Geppert, and M Khvotchev, and V Krasnoperov, and Y Goda, and M Missler, and R E Hammer, and K Ichtchenko, and A G Petrenko, and T C Südhof
February 1999, The Journal of biological chemistry,
M Geppert, and M Khvotchev, and V Krasnoperov, and Y Goda, and M Missler, and R E Hammer, and K Ichtchenko, and A G Petrenko, and T C Südhof
February 2002, The Journal of biological chemistry,
M Geppert, and M Khvotchev, and V Krasnoperov, and Y Goda, and M Missler, and R E Hammer, and K Ichtchenko, and A G Petrenko, and T C Südhof
March 2000, Molecular pharmacology,
M Geppert, and M Khvotchev, and V Krasnoperov, and Y Goda, and M Missler, and R E Hammer, and K Ichtchenko, and A G Petrenko, and T C Südhof
May 2000, Biochimie,
M Geppert, and M Khvotchev, and V Krasnoperov, and Y Goda, and M Missler, and R E Hammer, and K Ichtchenko, and A G Petrenko, and T C Südhof
June 1993, FEBS letters,
M Geppert, and M Khvotchev, and V Krasnoperov, and Y Goda, and M Missler, and R E Hammer, and K Ichtchenko, and A G Petrenko, and T C Südhof
November 1998, The EMBO journal,
Copied contents to your clipboard!